A prospective comparison of hepatotoxicity of the two currently available non-nucleoside reverse transcriptase inhibitors in a homogeneous case-mix of HIV-infected patients treated for the first time with efavirenz or nevirapine, according to their different baseline conditions / R. Manfredi; L. Calza; F. Chiodo. - In: ANTIVIRAL THERAPY. - ISSN 1359-6535. - STAMPA. - 10 Suppl.3:(2005), pp. L56-L57. (Intervento presentato al convegno Intl. Conference on Lipodistrophy tenutosi a Edinburgh (UK) nel ottobre 2005).
A prospective comparison of hepatotoxicity of the two currently available non-nucleoside reverse transcriptase inhibitors in a homogeneous case-mix of HIV-infected patients treated for the first time with efavirenz or nevirapine, according to their different baseline conditions
MANFREDI, ROBERTO;CALZA, LEONARDO;CHIODO, FRANCESCO
2005
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
